Arca biopharma announces fiscal year 2019 financial results and provides corporate update

U.s. fda special protocol assessment agreement for a single pivotal phase 3 clinical trial (precision-af) of genetically-targeted gencaroprecision-af...
ABIO Ratings Summary
ABIO Quant Ranking